About Cellular Dynamics International (NASDAQ:ICEL)
Cellular Dynamics International, Inc. develops and produces functioning human cells in industrial quantities. The Company's products include true human cells in multiple cell types (iCell products), human induced pluripotent stem cells (iPSCs) and custom iPSCs and iCell products (MyCell products). It markets its products for use in life science in vitro research and development, as well as applied product testing, stem cell banking and in vivo cellular therapeutics. It is also in the process of developing human cells as cellular therapeutics. The market for in vitro drug discovery, toxicity testing and applied testing, including chemical safety, has employed models, such as primary cells, transformed (immortalized) cells and live animals that act as surrogates for functioning human cells. Its iCell and MyCell products consist of iCell Cardiomyocytes, iCell Neurons, iCell DopaNeurons, iCell Endothelial Cells, iCell Hepatocytes, MyCell and Media and reprogramming kit.
Industry, Sector and Symbol
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
EPS (Most Recent Fiscal Year)N/A
Return on Equity-57.59%
Return on Assets-38.09%
Cellular Dynamics International (NASDAQ:ICEL) Frequently Asked Questions
What is Cellular Dynamics International's stock symbol?
Cellular Dynamics International trades on the NASDAQ under the ticker symbol "ICEL."
How were Cellular Dynamics International's earnings last quarter?
Cellular Dynamics International Inc (NASDAQ:ICEL) issued its earnings results on Thursday, March, 5th. The company reported ($0.36) EPS for the quarter, topping the Thomson Reuters' consensus estimate of ($0.44) by $0.08. The company earned $6.60 million during the quarter, compared to the consensus estimate of $5 million. Cellular Dynamics International had a negative return on equity of 57.59% and a negative net margin of 88.12%. View Cellular Dynamics International's Earnings History.
Has Cellular Dynamics International been receiving favorable news coverage?
Headlines about ICEL stock have been trending somewhat positive recently, according to Accern. The research group identifies negative and positive media coverage by monitoring more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Cellular Dynamics International earned a daily sentiment score of 0.08 on Accern's scale. They also gave media coverage about the company an impact score of 46.25 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company's share price in the near term.
How do I buy shares of Cellular Dynamics International?
Shares of ICEL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Cellular Dynamics International's stock price today?
One share of ICEL stock can currently be purchased for approximately $16.55.
How big of a company is Cellular Dynamics International?
Cellular Dynamics International has a market capitalization of $261.72 million.
How can I contact Cellular Dynamics International?
Cellular Dynamics International's mailing address is 525 Science Dr, MADISON, WI 53711-1082, United States. The company can be reached via phone at +1-608-3105100.
MarketBeat Community Rating for Cellular Dynamics International (ICEL)MarketBeat's community ratings are surveys of what our community members think about Cellular Dynamics International and other stocks. Vote "Outperform" if you believe ICEL will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ICEL will underperform the S&P 500 over the long term. You may vote once every thirty days.
Cellular Dynamics International (NASDAQ:ICEL) Analyst Ratings History
(Data available from 4/24/2016 forward)
|Date||Brokerage||Action||Rating||Price Target||Impact on Share Price||Details|
Cellular Dynamics International (NASDAQ:ICEL) Earnings History and Estimates Chart
Cellular Dynamics International (NASDAQ ICEL) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|3/5/2015||Q414||($0.44)||($0.36)||$5.00 million||$6.60 million||View||N/A|
|11/10/2014||Q314||($0.49)||($0.52)||$4.00 million||$1.80 million||View||N/A|
|8/11/2014||Q214||($0.48)||($0.54)||$4.62 million||$3.64 million||View||N/A|
|5/5/2014||Q1||($0.34)||($0.52)||$4.66 million||$2.90 million||View||N/A|
|3/10/2014||Q413||($0.30)||($0.43)||$4.27 million||$4.20 million||View||N/A|
|11/12/2013||Q3 2013||($0.33)||($0.62)||$2.90 million||$2.52 million||View||N/A|
|8/29/2013||Q2 13||($2.92)||$2.88 million||$2.81 million||View||N/A|
Cellular Dynamics International (NASDAQ:ICEL) Dividend History by Quarter
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Cellular Dynamics International (NASDAQ ICEL) Insider Trading and Institutional Ownership History
Cellular Dynamics International (NASDAQ ICEL) Insider Trading History
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
|7/24/2013||Floor Investors Lp Sixth||Director||Buy||40,000||$12.00||$480,000.00|| |
Cellular Dynamics International (NASDAQ ICEL) News Headlines
Cellular Dynamics International (NASDAQ:ICEL) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Cellular Dynamics International (NASDAQ:ICEL) Income Statement, Balance Sheet and Cash Flow Statement
Cellular Dynamics International (NASDAQ ICEL) Stock Chart for Tuesday, April, 24, 2018